GTXO yields 40000.00% · ABBV yields 3.06%● Live data
📍 GTXO pulled ahead of the other in Year 1
Combined, GTXO + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GTXO + ABBV for your $10,000?
GTX Corp. designs, develops, manufactures, and sells various products and services in the personal location services marketplace in the United States and internationally. The company offers global positioning system (GPS), Bluetooth low energy (BLE), and cellular location platform that enables subscribers to track in real time the whereabouts of people, pets, or high valued assets through a miniaturized transceiver module, wireless connectivity gateway, middleware, and viewing portal. Its products include GPS SmartSole, a wearable orthotic insole GPS tracking, monitoring, and recovery solution for those at risk of wandering due to Alzheimer's, dementia, and autism; Take Along Tracker 4G, a miniature tracking and SOS device; Sole Protector for GPS Smartsole; Take Along Friends & the Invisabelt, a GPS cellular tracking and monitoring device for young children and toddlers; Protective Medical devices and supplies, such as masks, sanitizers, face shields, UV wands, and various equipment, as well as antibody and antigen rapid test kits and hearing assisted technologies; and VeriTap, an near field communications (NFC) tag and middleware application to monitor logistics and assets in the supply chain. The company also develops and owns LOCiMOBILE, a suite of mobile tracking applications that turn smartphones and tablets, such as iPhone, iPad, Google Android, and other GPS enabled handsets into a tracking and location based real-time tracking device, which can be viewed through its tracking portal or on any connected device with internet access. In addition, it offers Track My Work Force, which allows employers to track and monitor employees, drivers, sales representatives, and others using their smartphones, tablets, or other wireless devices; and other applications. The company serves the consumer, enterprise, and military markets. GTX Corp. has collaboration with TulsaLabs. GTX Corp was founded in 2002 and is headquartered in Los Angeles, California.
Full GTXO Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.